Stay updated on PAAP for Pralsetinib in NSCLC and MTC Clinical Trial

Sign up to get notified when there's something new on the PAAP for Pralsetinib in NSCLC and MTC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PAAP for Pralsetinib in NSCLC and MTC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Medullary thyroid carcinoma is now listed as a condition, and the Genetic and Rare Diseases Information Center has been added to the Resources section.
    Difference
    0.2%
    Check dated 2026-04-02T15:14:42.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0, replacing v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:43:47.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is shown instead of v3.4.2. There are no visible changes to the study information or user actions on the page.
    Difference
    0.1%
    Check dated 2026-03-12T00:00:38.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the funding-status notice and the previous Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-11T14:11:21.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    A site-wide funding/status notice was added, and the page version was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-04T10:16:57.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Updates are limited to UI and metadata changes: glossary display toggle, updated QC status wording, No FEAR Act Data label, and a new Revision: v3.4.0 replacing v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-28T05:56:00.000Z thumbnail image

Stay in the know with updates to PAAP for Pralsetinib in NSCLC and MTC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PAAP for Pralsetinib in NSCLC and MTC Clinical Trial page.